Page last updated: 2024-08-23

idarubicin and Genetic Predisposition

idarubicin has been researched along with Genetic Predisposition in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pan, J; Zhang, X	1
Gou, H; Hu, X; Lu, X; Peng, W; Shang, M; Song, X; Ye, Y; Ying, B; Zhang, J; Zhao, Z; Zhou, J; Zhou, Y	1
Beltrão, EI; Benicio, MT; Bezerra, MA; Bezerra, MF; Coelho-Silva, JL; Lucena-Araujo, AR; Machado, CG; Nascimento, JC; Rego, EM; Rocha, CR	1
Bellaaj, H; Elloumi, M; Kallel, C; Kammoun, H; Kassar, O; Sandi, HS	1
Go, RS; Johnston, KL	1
Bolognesi, E; Cimino, G; D'Alfonso, S; Diverio, D; Fleischhauer, K; Migliaretti, G; Momigliano-Richiardi, P; Rapanotti, MC	1

Reviews

2 review(s) available for idarubicin and Genetic Predisposition

Article	Year
[Klinefelter syndrome and acute myeloblastic leukaemia]. Presse medicale (Paris, France : 1983), 2009, Volume: 38, Issue:6 Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 8; Cytarabine; Cytogenetics; Genetic Predisposition to Disease; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Karyotyping; Klinefelter Syndrome; Leukemia, Myeloid, Acute; Male; Trisomy	2009
Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome. European journal of haematology, 2003, Volume: 70, Issue:4 Topics: Abnormalities, Multiple; Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Cytokines; Female; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Menorrhagia; Neoplasm Proteins; Platelet Count; Proto-Oncogene Proteins; Radius; Receptors, Cytokine; Receptors, Thrombopoietin; Recurrence; Remission Induction; Risk; Syndrome; Thrombocytopenia	2003

Article

Year

[Klinefelter syndrome and acute myeloblastic leukaemia].

Presse medicale (Paris, France : 1983), 2009, Volume: 38, Issue:6

Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 8; Cytarabine; Cytogenetics; Genetic Predisposition to Disease; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Karyotyping; Klinefelter Syndrome; Leukemia, Myeloid, Acute; Male; Trisomy

2009

Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome.

European journal of haematology, 2003, Volume: 70, Issue:4

Topics: Abnormalities, Multiple; Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Cytokines; Female; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Menorrhagia; Neoplasm Proteins; Platelet Count; Proto-Oncogene Proteins; Radius; Receptors, Cytokine; Receptors, Thrombopoietin; Recurrence; Remission Induction; Risk; Syndrome; Thrombocytopenia

2003

Other Studies

4 other study(ies) available for idarubicin and Genetic Predisposition

Article	Year
A novel clonal t(1;4)(p36.1;q31) translocation in acute promyelocytic leukaemia. Journal of clinical pathology, 2015, Volume: 68, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 4; Female; Genetic Predisposition to Disease; Humans; Idarubicin; Karyotype; Karyotyping; Leukemia, Promyelocytic, Acute; Phenotype; Remission Induction; Translocation, Genetic; Treatment Outcome; Tretinoin	2015
The prevalence and clinical profiles of FLT3-ITD, FLT3-TKD, NPM1, C-KIT, DNMT3A, and CEBPA mutations in a cohort of patients with de novo acute myeloid leukemia from southwest China. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; CCAAT-Enhancer-Binding Proteins; China; Cytarabine; Daunorubicin; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; DNA Mutational Analysis; Female; fms-Like Tyrosine Kinase 3; Gene Frequency; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Neoplasm Proteins; Nuclear Proteins; Nucleophosmin; Oncogene Proteins, Fusion; Proto-Oncogene Proteins c-kit; Retrospective Studies; Treatment Outcome; Young Adult	2016
Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia. Haematologica, 2017, Volume: 102, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Alleles; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Etoposide; Female; Gene Expression; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Retrospective Studies; Survival Analysis; Thioguanine; Tumor Suppressor Protein p53	2017
HLA class I in acute promyelocytic leukemia (APL): possible correlation with clinical outcome. Leukemia, 2000, Volume: 14, Issue:3 Topics: Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; HLA-A Antigens; HLA-B Antigens; HLA-B13 Antigen; HLA-C Antigens; Humans; Idarubicin; Italy; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Prognosis; Remission Induction; Risk; Treatment Outcome; Tretinoin	2000